Abilify
Active substance: aripiprazole
aripiprazole
Centralised EU authorisationActive
Marketing holder: Otsuka Pharmaceutical Netherlands B.V.
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 20 |
|
| US 272 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-336d-70f9-a164-474f33402116,01a120c3-3d95-70ca-a87a-c40a223c6456,01a120c3-4822-70a1-8743-0881ce00e860,01a120c3-4aa6-7113-be50-461a50d0c12e,01a120c3-7bd5-7988-93ff-e3264589e1d7;count=14 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2cc6-79cb-bd03-518f94fa101a,01a1208c-2d5b-77a6-97bd-d2e8da5797f6,01a1208c-2d5c-7420-a308-c0fb77cfccdd,01a1208c-30bd-77b2-a9ef-ae05b64d6165,01a1208c-30be-7554-a5de-ba7a00a02a5f;count=272 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- EMEA/H/C/000471
- Registration status
- Active
- ATC code
- N05AX12
- product · EMA · EMEA/H/C/000471 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/000471 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/000471 · Verified 2026-10-09